Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS

References

• Poser CM, Johnson M, Bunch LD. Serum Amino Acid Studies in Amyotrophic Lateral Sclerosis I. Results of Arginine Tolerance Tests. Arch Neurol. 1965;12:604–9.
   Google Scholar
• Bowser R, Lacomis D. Applying proteomics to the diagnosis and treatment of ALS and related diseases. Muscle Nerve. 2009;40:753–62.
   PubMed Web of Science ®Google Scholar
• Ryberg H, Bowser R. Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev Proteomics. 2008;5:249–62.
   PubMed Web of Science ®Google Scholar
• Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009;8:94–109.
   PubMed Web of Science ®Google Scholar
• Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, . Amyotrophic lateral sclerosis. Lancet. 2011 (Early Online Publication, February 7 2011).
   PubMed Web of Science ®Google Scholar
• Poste G. Bring on the biomarkers. Nature. 2011;469:156–7.
   PubMed Web of Science ®Google Scholar
• Turner MR, Grosskreutz J, Kassubek J, Abrahams S, Agosta F, Benatar M, . Towards a neuroimaging biomarker in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:400–3.
   PubMed Web of Science ®Google Scholar
• Sherman A, Bowser R, Grasso D, Power B, Milligan C, Jaffa M, . Proposed BioRepository platform solution for the ALS research community. Amyotroph Lateral Scler. 2011;12:11–6.
   PubMed Web of Science ®Google Scholar
• Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, . A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73:1914–22.
   PubMed Web of Science ®Google Scholar
• Brettschneider J, Petzold A, Sussmuth SD, Ludolph AC, Tumani H. Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology. 2006;66:852–6.
   PubMed Web of Science ®Google Scholar
• Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem. 2011;117:528–37.
   PubMed Web of Science ®Google Scholar
• Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci. 2005;233:183–98.
   PubMed Web of Science ®Google Scholar
• Boylan K, Yang C, Crook J, Overstreet K, Heckman M, Wang Y, . Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. J Neurochem. 2009;111:1182–91.
   PubMed Web of Science ®Google Scholar
• Jesse S, Brettschneider J, Sussmuth SD, Landwehrmeyer BG, von Arnim CA, Ludolph AC, . Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases. J Neurol. 2011;258:1034–41.
   PubMed Web of Science ®Google Scholar
• Zetterberg H, Tullhog K, Hansson O, Minthon L, Londos E, Blennow K. Low incidence of post-lumbar puncture headache in 1089 consecutive memory clinic patients. Eur Neurol. 2010;63:326–30.
   PubMed Web of Science ®Google Scholar
• Ranganathan S, Polshyna A, Nicholl G, Lyons-Weiler J, Bowser R. Assessment of protein stability in cerebrospinal fluid using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry protein profiling. Clin Proteomics. 2006;2:91–101.
   PubMedGoogle Scholar
• Rosenling T, Slim CL, Christin C, Coulier L, Shi S, Stoop MP, . The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF). J Proteome Res. 2009;8:5511–22.
   PubMed Web of Science ®Google Scholar
• Wuolikainen A, Hedenstrom M, Moritz T, Marklund SL, Antti H, Andersen PM. Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS. Amyotroph Lateral Scler. 2009;10:229–36.
   PubMed Web of Science ®Google Scholar
• Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37:234–44.
   PubMed Web of Science ®Google Scholar
• Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet. 2010;19:2284–302.
   PubMed Web of Science ®Google Scholar
• Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479–86.
   PubMed Web of Science ®Google Scholar
• Ferrer I, Santpere G, Arzberger T, Bell J, Blanco R, Boluda S, . Brain protein preservation largely depends on the post mortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study. J Neuropathol Exp Neurol. 2007;66:35–46.
   PubMed Web of Science ®Google Scholar
• Durrenberger PF, Fernando S, Kashefi SN, Ferrer I, Hauw JJ, Seilhean D, . Effects of ante mortem and post mortem variables on human brain mRNA quality: a BrainNet Europe study. J Neuropathol Exp Neurol. 2010;69:70–81.
   PubMed Web of Science ®Google Scholar
• Steinacker P, Rist W, Swiatek-de-Lange M, Lehnert S, Jesse S, Pabst A, . Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease. Proteomics. 2010;10:81–9.
   PubMed Web of Science ®Google Scholar
• Tumani H, Lehmensiek V, Lehnert S, Otto M, Brettschneider J. 2D DIGE of the cerebrospinal fluid proteome in neurological diseases. Expert Rev Proteomics. 2010;7:29–38.
   PubMed Web of Science ®Google Scholar
• Geiger T, Wisniewski JR, Cox J, Zanivan S, Kruger M, Ishihama Y, . Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat Protoc. 2011;6:147–57.
   PubMed Web of Science ®Google Scholar
• Patel VJ, Thalassinos K, Slade SE, Connolly JB, Crombie A, Murrell JC, . A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J Proteome Res. 2009;8:3752–9.
   PubMed Web of Science ®Google Scholar
• Ramstrom M, Ivonin I, Johansson A, Askmark H, Markides KE, Zubarev R, . Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry. Proteomics. 2004;4:4010–8.
   PubMed Web of Science ®Google Scholar
• Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, . A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology. 2009;72:14–9.
   PubMed Web of Science ®Google Scholar
• Mitchell RM, Simmons Z, Beard JL, Stephens HE, Connor JR. Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve. 2010;42:95–103.
   PubMed Web of Science ®Google Scholar
• Levin Y, Wang L, Schwarz E, Koethe D, Leweke FM, Bahn S. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol Psychiatry. 2009;15:1088–100.
   PubMed Web of Science ®Google Scholar
• Brechlin P, Jahn O, Steinacker P, Cepek L, Kratzin H, Lehnert S, . Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease. Proteomics. 2008;8:4357–66.
   PubMed Web of Science ®Google Scholar
• Guerrier L, Righetti PG, Boschetti E. Reduction of dynamic protein concentration range of biological extracts for the discovery of low-abundance proteins by means of hexapeptide ligand library. Nat Protoc. 2008;3:883–90.
   PubMed Web of Science ®Google Scholar
• Mouton-Barbosa E, Roux-Dalvai F, Bouyssie D, Berger F, Schmidt E, Righetti PG, . In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification. Mol Cell Proteomics. 2010;9:1006–21.
   PubMed Web of Science ®Google Scholar
• Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol. 2008;4:222.
   PubMed Web of Science ®Google Scholar
• Espina V, Heiby M, Pierobon M, Liotta LA. Laser capture microdissection technology. Expert Rev Mol Diagn. 2007;7:647–57.
   PubMed Web of Science ®Google Scholar
• Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, . MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549–54.
   PubMed Web of Science ®Google Scholar
• Rozen S, Cudkowicz ME, Bogdanov M, Matson WR, Kristal BS, Beecher C, . Metabolomic analysis and signatures in motor neuron disease. Metabolomics. 2005;1:101–8.
   PubMed Web of Science ®Google Scholar
• Wuolikainen A, Moritz T, Marklund SL, Antti H, Andersen PM. Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. PLoS One. 2011;6:17947.
   PubMed Web of Science ®Google Scholar
• Sansone SA, Fan T, Goodacre R, Griffin JL, Hardy NW, Kaddurah-Daouk R, . The metabolomics standards initiative. Nat Biotechnol. 2007;25:846–8.
   PubMed Web of Science ®Google Scholar
• Quinn PJ, Rainteau D, Wolf C. Lipidomics of the red cell in diagnosis of human disorders. Methods Mol Biol. 2009;579:127–59.
   PubMedGoogle Scholar
• Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47:348–80.
   PubMed Web of Science ®Google Scholar